Workflow
Aier(300015)
icon
Search documents
爱尔眼科回应精神病院套保,股价急跌3%
记者丨韩利明 朱艺艺 编辑丨季媛媛 精神病医院涉嫌骗取医保基金事件持续发酵。 2月3日,《新京报》调查披露,襄阳、宜昌多家精神病医院存在违规收治正常人、虚构诊疗项目、高额收取治疗费等行为,通过"假出院"规避监管或阻挠康 复患者出院,将其作为"创收工具"套取医保资金。 事件进一步牵出资本市场关联。2月5日晚间有媒体指出,涉案的襄阳恒泰康医院实际控制人为爱尔眼科(300015.SZ)实控人陈邦。 对此,爱尔眼科相关人士向21世纪经济报道记者回应,"爱尔眼科医院集团股份有限公司为独立上市公司,爱尔医疗投资集团为其主要股东,持股比例为 34.34%。爱尔眼科拥有独立的法人治理结构、管理体系和财务体系,依法依规独立运营;在现有股权及业务体系中,爱尔眼科与恒泰康康复医疗集团及其 下属机构不存在股权控制、业务关联或经营管理关系。" 不过,据爱尔眼科2024年年报信息,爱尔医疗投资集团有限公司成立于2007年9月,陈邦为其法定代表人/单位负责人。 对于双方的关系,2月6日,21世纪经济报道记者联系爱尔眼科相关人士获得一份回应称,"襄阳恒泰康医院有限公司并非爱尔眼科体系内企业。该公司为爱 尔医疗投资集团有限公司与其他社会资本方 ...
爱尔眼科回应董事长陈邦被指关联“骗保”精神病院传闻:不直接参与经营管理
Guan Cha Zhe Wang· 2026-02-06 06:14
Core Viewpoint - Recent reports indicate that several private psychiatric hospitals in Hubei, including Xiangyang and Yichang, have been accused of misleading patients into hospitalization with "free hospitalization" promotions and defrauding medical insurance funds through fictitious treatment projects. The Xiangyang Hengtai Kang Hospital is linked to Chen Bang, the chairman of Aier Eye Hospital, as its ultimate actual controller [1][3]. Group 1: Company Structure and Relationships - Aier Eye Hospital clarified that Xiangyang Hengtai Kang Hospital is not part of its listed company structure and is a joint venture established with other social capital by Aier Medical Investment Group, thus not included in Aier Eye's consolidated financial statements [4]. - Aier Eye Hospital stated that Chen Bang, as one of the investors, does not directly participate in the management of Hengtai Kang Hospital [4]. - Aier Eye Hospital emphasized that it operates independently with its own governance, management, and financial systems, and that Aier Medical Investment Group holds a 34.34% stake in it [4]. Group 2: Response to Allegations - Aier Eye Hospital expressed its support for the ongoing investigations by national authorities regarding the alleged violations by psychiatric hospitals and maintains a zero-tolerance policy towards any illegal activities [4]. - The company urged the public and investors to rely on authoritative disclosures, business registrations, and official announcements from the listed company for accurate information [5]. Group 3: Background of Chen Bang - Chen Bang, a former military personnel, transitioned from various industries, including real estate, to the medical field, recognizing the market potential in private ophthalmology during a health recovery period [7].
爱尔眼科公告,说明与襄阳恒泰康关系
Core Viewpoint - Aier Eye Hospital Group clarifies its non-involvement with Xiangyang Hengtai Kang Hospital amid media reports linking the two, emphasizing its commitment to legal compliance and patient rights protection [1][2] Group 1: Company Clarification - Aier Eye Hospital states that Xiangyang Hengtai Kang Hospital is not a subsidiary and is managed independently by its own team [1] - The company asserts that it has no equity control, business ties, or management relationship with Hengtai Kang Rehabilitation Medical Industry Development Co., Ltd. [1] - Aier Eye Hospital maintains a "zero tolerance" policy towards any illegal activities [1] Group 2: Financial Performance - For the first three quarters of 2025, Aier Eye Hospital reported total revenue of approximately 17.484 billion yuan, a year-on-year increase of 7.25% [2] - The net profit attributable to shareholders for the same period was about 3.115 billion yuan, reflecting a year-on-year decrease of 9.76% [2] - As of February 6, the company's stock price decreased by 3.13%, trading at 11.16 yuan per share [2]
爱尔眼科发布澄清公告:与恒泰康不存在直接股权或经营管理关系
Cai Jing Wang· 2026-02-06 05:38
3、爱尔眼科与湖南恒泰康康复医疗产业发展有限公司及其下属机构不存在股权控制、业务关联或经营 管理关系。 公司及实际控制人陈邦先生始终坚持依法合规经营,严格执行国家关于医疗服务、医保基金使用和患者 权益保护的相关法律法规,对任何违法违规行为持"零容忍"态度。 2月6日,爱尔眼科(300015)发布公告称,关注到部分媒体关于精神专科医院涉嫌违规问题的报道中, 将襄阳恒泰康医院有限公司(以下简称"襄阳恒泰康")与爱尔眼科直接关联。为避免相关传闻对广大投 资者及社会公众造成误导,切实维护投资者合法权益,公司现就有关情况澄清说明如下: 1、襄阳恒泰康非爱尔眼科所属企业。该公司为爱尔医疗投资集团有限公司(以下简称"爱尔医疗投 资")与其他投资方合资设立的四级子公司。 2、襄阳恒泰康由其医院管理团队经营。爱尔医疗投资不参与襄阳恒泰康的日常经营管理。 ...
精神病院套保牵出A股眼科连锁巨头?爱尔眼科回应
Core Viewpoint - The investigation into mental health hospitals in Xiangyang and Yichang for allegedly defrauding medical insurance funds has raised concerns about the involvement of Aier Eye Hospital and its actual controller, Chen Bang [1][2][4]. Group 1: Allegations Against Mental Health Hospitals - Multiple mental health hospitals in Xiangyang and Yichang have been accused of illegally admitting healthy individuals, fabricating treatment projects, and charging exorbitant fees, using "fake discharges" to evade regulation [1][2]. - The hospitals reportedly recruited patients under the guise of "free hospitalization" and even had internal staff impersonate patients to exploit insurance funds [2][3]. Group 2: Connection to Aier Eye Hospital - The Xiangyang Hengtai Kang Hospital, linked to the allegations, is controlled by Chen Bang, who is also the actual controller of Aier Eye Hospital [2][4]. - Aier Eye Hospital has stated that Xiangyang Hengtai Kang Hospital is not part of its corporate structure and that Chen Bang does not directly manage its operations [2][4]. Group 3: Market Reaction - Following the news, Aier Eye Hospital's stock price fell by 3.48% to 11.11 CNY per share, with a total market capitalization of 103.6 billion CNY as of February 6 [2][4]. Group 4: Regulatory Response - A joint investigation team has been established by Hubei Province to conduct an in-depth investigation into the allegations against the mental health hospitals [7]. - The National Medical Insurance Administration has announced plans for special inspections of mental health institutions this year, with strict penalties for those found violating regulations [7]. Group 5: Aier Eye Hospital's Business Overview - Aier Eye Hospital, founded in 2009, has expanded rapidly, with total revenue growing from 2.4 billion CNY in 2014 to 20.98 billion CNY in 2024, and net profit increasing from 309 million CNY to 3.56 billion CNY in the same period [12]. - The company operates 355 hospitals and 240 outpatient departments in China, along with 169 overseas eye care centers [11][12]. Group 6: Concerns and Risks - The rapid expansion of Aier Eye Hospital has led to numerous consumer complaints, with over 70 medical malpractice cases reported between 2014 and 2020 [13]. - The company's goodwill reached 8.79 billion CNY by the third quarter of 2025, significantly exceeding its fixed assets and cash reserves [14].
爱尔眼科回应“控股骗保精神病院”
Core Viewpoint - Aier Eye Hospital (300015) clarifies its non-involvement with Xiangyang Hengtai Kang Hospital amid media reports linking the two, aiming to protect investor interests and prevent misinformation Group 1: Company Clarification - Xiangyang Hengtai Kang is not owned by Aier Eye Hospital but is a joint venture established by Aier Medical Investment Group and other investors [1] - Aier Medical Investment does not participate in the daily operations of Xiangyang Hengtai Kang, which is managed by its own hospital management team [2] - There is no equity control, business relationship, or operational management connection between Aier Eye Hospital and Hunan Hengtai Kang Rehabilitation Medical Industry Development Co., Ltd. [3] Group 2: Market Impact - As of February 6, Aier Eye Hospital's stock fell by 3.48%, with a market capitalization of 103.6 billion CNY [6]
爱尔眼科澄清与襄阳恒泰康无股权及业务关联
Mei Ri Jing Ji Xin Wen· 2026-02-06 04:56
3.爱尔眼科与湖南恒泰康康复医疗产业发展有限公司及其下属机构不存在股权控制、业务关联或经营管 理关系。 【#爱尔眼科澄清与襄阳恒泰康关系#】爱尔眼科2月6日午间发布公告称,近日,爱尔眼科医院集团股份 有限公司关注到部分媒体关于精神专科医院涉嫌违规问题的报道中,将襄阳恒泰康医院有限公司与爱尔 眼科直接关联。为避免相关传闻对广大投资者及社会公众造成误导,切实维护投资者合法权益,公司现 就有关情况澄清说明如下: 2.襄阳恒泰康由其医院管理团队经营。爱尔医疗投资不参与襄阳恒泰康的日常经营管理。 爱尔眼科表示,公司及实际控制人陈邦始终坚持依法合规经营,严格执行国家关于医疗服务、医保基金 使用和患者权益保护的相关法律法规,对任何违法违规行为持"零容忍"态度。(每经,德塔) 爱尔眼科医院集团股份有限公司 澄清公告 1.襄阳恒泰康非爱尔眼科所属企业。该公司为爱尔医疗投资集团有限公司与其他投资方合资设立的四级 子公司。 3、爱尔眼科与湖南恒泰康康复医疗产业发展有限公司及其下属机构不存在 股权控制、业务关联或经营管合关系。 参考编图 一、媒体报道简述 近日,爱尔眼科医院集团股份有限公司(以下简称"公司""爱尔眼科") 关注到部分 ...
爱尔眼科,最新声明!
券商中国· 2026-02-06 04:55
近日,湖北多家精神病医院被曝虚构诊疗项目、套取医保资金,引发广泛关注。据《新京报》报道,涉事 医院包括襄阳融诚医院、襄阳宏安医院、襄阳恒泰康医院、宜昌夷陵康宁精神病医院等。有媒体报道称, 被点名的襄阳恒泰康医院在股权穿透后,实际控制人为A股上市公司爱尔眼科董事长、实际控制人陈邦。 2月6日,澎湃新闻记者电话联系了上市后公司爱尔眼科(300015.SZ)的证券部门,相关工作人员表示, 看到新闻了,但确实不属于上市公司体系内的,"爱尔眼科上市公司与襄阳恒泰康医院在经营和相关业务 方面都没有关联,这个我们清楚"。 同日上午,爱尔眼科发布声明,全文如下: 针对近日部分媒体关于精神专科医院涉嫌违规问题的报道中,将襄阳恒泰康医院有限公司与爱尔眼科 医院集团股份有限公司(以下简称"爱尔眼科")及其实际控制人陈邦直接关联的情况,爱尔眼科向本 报发来书面回应,对相关股权关系及企业边界作出说明。 爱尔眼科方面表示,相关报道中部分表述存在概念混用,可能引发公众误解。 一、关于襄阳恒泰康医院的股权层级 爱尔眼科方面称,襄阳恒泰康医院有限公司并非爱尔眼科上市公司体系内企业。该公司为爱尔医疗投 资集团有限公司与其他社会资本方合资设立的四 ...
董事长被指疑为“骗保”精神病院实控人,爱尔眼科声明
Sou Hu Cai Jing· 2026-02-06 04:49
天眼查截图 同日上午,爱尔眼科发布声明,全文如下: 针对近日部分媒体关于精神专科医院涉嫌违规问题的报道中,将襄阳恒泰康医院有限公司与爱尔眼科医院集团股份有限公司(以下简称"爱尔眼 科")及其实际控制人陈邦直接关联的情况,爱尔眼科向本报发来书面回应,对相关股权关系及企业边界作出说明。 智通财经记者 李潇潇 近日,湖北多家精神病医院被曝虚构诊疗项目、套取医保资金,引发广泛关注。据《新京报》报道,涉事医院包括襄阳融诚医院、襄阳宏安医 院、襄阳恒泰康医院、宜昌夷陵康宁精神病医院等。有媒体报道称,被点名的襄阳恒泰康医院在股权穿透后,实际控制人为A股上市公司爱尔眼 科董事长、实际控制人陈邦。 针对部分报道将恒泰康康复医疗集团与爱尔眼科并列为"同一体系"或"同属一个集团"的说法,爱尔眼科方面回应称,在现有股权及业务体系中, 爱尔眼科与恒泰康康复医疗集团及其下属机构不存在股权控制、业务关联或经营管理关系。 四、关于相关调查事件的态度 对于媒体披露的部分精神专科医院涉嫌违规收治、套取医保资金等问题,爱尔眼科方面表示,已关注到国家有关部门正在开展的调查,并坚决支 持依法依规查清事实。同时表示,公司始终坚持依法合规经营,严格执行国 ...
爱尔眼科,最新公告
财联社· 2026-02-06 04:48
针对近日部分媒体关于精神专科医院涉嫌违规问题的报道中,将襄阳恒泰康医院有限公司与爱尔眼科医院集团股份有限公司及其实际控制人 陈邦直接关联的情况,爱尔眼科方面今日作出回应。 爱尔眼科公告表示,公司关注到部分媒体关于精神专科医院涉嫌违规问题的报道中,将襄阳恒泰康医院有限公司与爱尔眼科直接关联。为避 免相关传闻对广大投资者及社会公众造成误导,切实维护投资者合法权益,公司现就有关情况澄清说明如下: 1、襄阳恒泰康非爱尔眼科所属企业。该公司为爱尔医疗投资集团有限公司(以下简称"爱尔医疗投资")与其他投资方合资设立的四级子公 司。 2、襄阳恒泰康由其医院管理团队经营。爱尔医疗投资不参与襄阳恒泰康的日常经营管理。 3、爱尔眼科与湖南恒泰康康复医疗产业发展有限公司及其下属机构不存在股权控制、业务关联或经营管理关系。 公司及实际控制人陈邦先生始终坚持依法合规经营,严格执行国家关于医疗服务、医保基金使用和患者权益保护的相关法律法规,对任何违 法违规行为持"零容忍"态度。 爱尔眼科医院集团股份有限公司 证券代码:300015 股票简称:爱尔眼科 公告编号:2026-006 爱尔眼科医院集团股份有限公司 澄清公告 一、媒体报道简述 ...